ECG vs EXPO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 21, 2026
ECG
EXPO
Investment Advisor Scores
EXPO
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ECG | EXPO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 19.2308 | 31.5457 | ECG |
| PEG Ratio | 0 | 2.0325 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 33.7% | 12.0% | ECG |
| Earnings Growth | 59.2% | 15.7% | ECG |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 33.1/100 | 39.5/100 | EXPO |
| Profit Margin | 6.0% | 19.7% | EXPO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | AVOID NEW MONEY | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ECG
MarkdownPrice below a falling SMA50 (slope -4.9%), weak momentum, RSI 26
EXPO
MarkupPrice above SMA50, rising 50-day trend (2.9% over 20 days), RSI 77
Fundamentals Snapshot
| Metric | ECG | EXPO |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 15.4 | 28.4 |
| Trailing P/E | 21.3 | 32.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.1% |
| Gross Margin | 0.1% | 0.4% |
| Operating Margin | 0.1% | 0.2% |
| EPS | 4.97 | 2.25 |
| Dividend Yield | — | 0.02% |